CD28 and Stroke: As the CD28 SA had no impact on stroke volumes (control group: 30.4±2.8 mm3; CD28 SA group: 37.3±12.5 mm3, P>0.05) (Figure 1A) a direct effect of the CD28 SA on clinical outcome in the absence of T and B cells could be excluded.